Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 54 Next >>

Filter Applied: adverse drug reaction (Click to remove)

Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Pseudotumor Cerebri
Adams & Victors Principles of Neurology, Chp 30, pg 628, Ropper, A.H.,et al, 2014

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

Migraine
NEJM 383:1866-1876, Ashina, M., 2020

Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019

Muscular Dystrophies
Lancet 394:2025-2038, Mercuri, E.,et al, 2019

Pembrolizumab-Induced Myasthenia Gravis
Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018

Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents
Stroke 48:1432-1437, Steiner, T.,et al, 2017

A 54-year-old woman with Dementia, Myoclonus, and Ataxia
Neurol 89:e7-e12, Ali, F.,et al, 2017

Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015

Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014

ICU-Acquired Weakness and Recovery from Critical Illness
NEJM 370:1626-1635, Kress, J.P. & Hall, J.B., 2014

Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013

Progressive Weakness with Respiratory Failure in a Patient with Sarcoidosis
Arch Neurol 69:534-537, Chaudhry,P.,et al, 2012

Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012

A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

A 75-Year-Old Man With Cognitive Impairment and Gait Changes, Lewy Body Disease
Neurol 69:1183-1189, Lippa,C.F.,et al, 2007

Delirium in Older Persons
NEJM 354:1157-1165, Inouye,S.K., 2006

Weight Change and Antiepileptic Drugs. Health Issues and Criteria for Appropriate Selection of an Antiepileptic Agent.
The Neurologist 12:163-167, Biton,V., 2006

Severe Botulism After Focal Injection of Botulinum Toxin
Neurol 67:1855-1856, Souayah,N.,et al, 2006

Botulism in 4 Adults Following Cosmetic Injections With an Unlicensed, Highly Concentrated Botulinum Preparation
JAMA 296:2476-2479,2512, Chertow,D.S.,et al, 2006

Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005

Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Sibutramine May Be Associated With Memory Impairment
BMJ 329:1316, Clark,D.W.J. &Harrison-Woolrych,M., 2004

Tinnitus
NEJM 347:904-910, Lockwood,A.H.,et al, 2002

Weight Change Associated with Valproate and Lamotrigine Monotherapy in Patients with Epilepsy
Neurol 56:172-177, Biton,V.,et al, 2001

Intoxication with Riluzole in Huntington's Diease
Neurol 57:1141-1143, Bodner,Th.,et al, 2001

Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000

An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Coma Induced by Abuse of Gamma-Hydroxybutyrate (GBH or Liquid Ecstasy) :A Case Report
BMJ 314:35-36, Thomas,G.,et al, 1997

Brain Serotonin Neurotoxicity & Primary Pulmonary Hypertension from Fenfluramine & Dexfenfluramine
JAMA 278:666-672, McCann,U.D.,et al, 1997

Complications of Intravenous Immune Globulin Treatment in Neurologic Disease
Neurol 47:674-677, Brannagan III,T.H.,et al, 1996

Obesity and Endocrine Disorders in Women Taking Valproate for Epilepsy
Ann Neurol 39:579-584, 5591996., Isojarvi,J.I.T.,et al, 1996

The Effect on Memory of Chronic Prednisone Treatment in Patients with Systemic Disease
Neurol 47:1396-1402, Keenan,P.A.,et al, 1996

Carbamazepine Hypersensitivity Syndrome:Report of 4 Cases & Review of Literature
Medicine 74:144-151, DeVriese,A.S.P.,et al, 1995

Risperidone
Lancet 343:457-460, Livingston,M.G., 1994

Hyperthermia and Heatstroke
Hospital Practice 29:65-68, 73, 78-80994., Simon,H.B., 1994

Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992

A Comparison of Valproate with Carbamazepine for the Treat of Complex Partial Seizures & Second General Seizures in Adults
NEJM 327:765-771, Mattson,R.H.,et al, 1992

Prolonged Weakness after Long-Term Infusion of Vecuronium Bromide
Ann Int Med 117:484-486, Kupfer,Y.,et al, 1992

Clozapine, A Novel Antipsychotic Agent
NEJM 324:746-754, Baldessarini,R.J.&Frankenburg,F.R., 1991

Eosinophilia-Myalgia Syndrome, A Clinical Case Series of 21 Patients
Arch Int Med 151:533-537, Philen,R.M.,et al, 1991

Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991

Aggravation of Myasthenia Gravis by Erythromycin
J Pediatr 119:155-156, Absher,J.R.&Bale,J.F., 1991

Prolonged Paralysis after Treatment with Neuromuscular Junction Blocking Agents
Crit Care Med 19:1125-1131, Gooch,J.L.,et al, 1991

Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991



Showing articles 0 to 50 of 54 Next >>